Abstract

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Gene Expression Profiling for Molecular Features of Response in a Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas
Michelle A Fanale ...
Blood | VOL. 126
Michelle A Fanale, et. al.Michelle A Fanale ...
03 Dec 2015
Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
Bertrand Coiffier ... Steven M Horwitz
Blood | VOL. 118
Bertrand Coiffier, et. al.Bertrand Coiffier ... Steven M Horwitz
18 Nov 2011
Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).
Richard Piekarz ... Susan Bates
Blood | VOL. 112
Richard Piekarz, et. al.Richard Piekarz ... Susan Bates
16 Nov 2008
Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results
Beata Holkova ... Steven Grant
Blood | VOL. 124
Beata Holkova, et. al.Beata Holkova ... Steven Grant
06 Dec 2014
View more papers

More From: Blood advances

Paper Title
Journal
Date
Author
HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin Lymphoma.
Amanda Chantziou ... Constantinos Petrovas
Blood Advances | VOL. -
Amanda Chantziou, et. al.Amanda Chantziou ... Constantinos Petrovas
08 Aug 2024
Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation.
Yaqiu Sang ... Alisa S Wolberg
Blood Advances | VOL. -
Yaqiu Sang, et. al.Yaqiu Sang ... Alisa S Wolberg
08 Aug 2024
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.
Binod Dhakal ... Kwee L Yong
Blood Advances | VOL. -
Binod Dhakal, et. al.Binod Dhakal ... Kwee L Yong
07 Aug 2024
Response to 'A call to improve reporting of infection events in clinical treatment trials...'
Heinz Ludwig ... Ajay K Nooka
Blood Advances | VOL. -
Heinz Ludwig, et. al.Heinz Ludwig ... Ajay K Nooka
07 Aug 2024
View more papers